Table 1. Correlation between lncRNA DBH-AS1 expression and clinicopathological characteristics in HCC patients (n=45).
Variables | lncRNA DBH-AS1 expression | x2 | *P Value | |
---|---|---|---|---|
Low | High# | |||
All cases | 22 | 23 | ||
Age | 0.218 | 0.641 | ||
>55 | 9 | 11 | ||
<=55 | 13 | 12 | ||
Gender | 0.505 | 0.477 | ||
Male | 19 | 18 | ||
Female | 3 | 5 | ||
HBsAg | 4.132 | 0.042* | ||
positive | 12 | 19 | ||
negative | 10 | 4 | ||
Liver cirrhosis | 1.779 | 0.182 | ||
with | 10 | 15 | ||
without | 12 | 8 | ||
AFP(ng/ml) | 0.192 | 0.661 | ||
>20 | 11 | 10 | ||
<=20 | 11 | 13 | ||
Tumor size(cm) | 8.006 | 0.005** | ||
>5cm | 7 | 17 | ||
<=5cm | 15 | 6 | ||
Tumor number | 0.505 | 0.477 | ||
solitary | 19 | 18 | ||
multiple | 3 | 5 | ||
Edmondson grade | 0.67 | 0.413 | ||
I+II | 2 | 4 | ||
III | 20 | 19 |
The median expression level was used as the cutoff. Low expression of lncRNA DBH-AS1 in 22 patients was classified as values below the 50th percentile. High lncRNA DBH-AS1 expression in 23 patients was classified as values at or above the 50th percentile.
For analysis of correlation between lncRNA DBH-AS1 levels and clinical features,Pearson's chi-square tests were used. *, P <0.05; **, P<0.01.